Clinical significance of random bladder biopsy in primary T1 bladder cancer

  • Authors:
    • Masafumi Otsuka
    • Satoru Taguchi
    • Tohru Nakagawa
    • Teppei Morikawa
    • Shigekatsu Maekawa
    • Jimpei Miyakawa
    • Akihiko Matsumoto
    • Hideyo Miyazaki
    • Tetsuya Fujimura
    • Hiroshi Fukuhara
    • Haruki Kume
    • Yasuhiko Igawa
    • Yukio Homma
  • View Affiliations

  • Published online on: March 8, 2018     https://doi.org/10.3892/mco.2018.1587
  • Pages: 665-670
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

The clinical significance of random bladder biopsies in primary non‑muscle‑invasive bladder cancer is unclear. The present study investigated the significance of positive random bladder biopsies in primary T1 NMIBC. The present study retrospectively reviewed the records of 71 patients with primary pT1N0M0 bladder cancer who underwent transurethral resection of the bladder tumor (TURBT) and concomitant random bladder biopsy. A total of 12 patients who received cystectomy immediately following the TURBT were excluded, and the remaining 59 patients were included in the analysis. Random bladder biopsy was defined as a cold‑cup biopsy of pre‑specified normal‑looking areas in the bladder. The association of clinicopathological factors, including random biopsy results, with intravesical recurrence were assessed by univariate and multivariate Cox proportional hazards analyses. Of the 59 patients, 15 (25%) demonstrated carcinoma in situ (CIS) lesions on random bladder biopsy: Five (33%) in biopsy specimens alone and the remaining 10 (67%) in biopsy and TUR specimens. Positive random biopsy was associated with preoperative positive urine cytology (P=0.011) and small size of the main tumor (P=0.008). Multivariate analysis demonstrated positive random biopsy as the sole independent poor prognostic factor for intravesical recurrence (hazard ratio: 4.69, P=0.014). The five patients who had CIS detected in biopsy specimens alone had worse, although non‑significantly worse, recurrence‑free survival compared with those with CIS detected in biopsy and TUR specimens (P=0.100). In conclusion, positive bladder random biopsy, equivalent to the presence of CIS, was an independent predictor of recurrence in primary T1 bladder cancer. Given that one‑third of CIS lesions could not have been detected without biopsy, random bladder biopsy should be considered for patients with T1 tumors.
View Figures
View References

Related Articles

Journal Cover

May 2018
Volume 8 Issue 5

Print ISSN: 2049-9450
Online ISSN:2049-9469

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Otsuka, M., Taguchi, S., Nakagawa, T., Morikawa, T., Maekawa, S., Miyakawa, J. ... Homma, Y. (2018). Clinical significance of random bladder biopsy in primary T1 bladder cancer. Molecular and Clinical Oncology, 8, 665-670. https://doi.org/10.3892/mco.2018.1587
MLA
Otsuka, M., Taguchi, S., Nakagawa, T., Morikawa, T., Maekawa, S., Miyakawa, J., Matsumoto, A., Miyazaki, H., Fujimura, T., Fukuhara, H., Kume, H., Igawa, Y., Homma, Y."Clinical significance of random bladder biopsy in primary T1 bladder cancer". Molecular and Clinical Oncology 8.5 (2018): 665-670.
Chicago
Otsuka, M., Taguchi, S., Nakagawa, T., Morikawa, T., Maekawa, S., Miyakawa, J., Matsumoto, A., Miyazaki, H., Fujimura, T., Fukuhara, H., Kume, H., Igawa, Y., Homma, Y."Clinical significance of random bladder biopsy in primary T1 bladder cancer". Molecular and Clinical Oncology 8, no. 5 (2018): 665-670. https://doi.org/10.3892/mco.2018.1587